Mirum Pharmaceuticals (MIRM) Operating Income Growth (1y) (2020 - 2026)
Mirum Pharmaceuticals (MIRM) Operating Income Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,071.81 Bn | - | -24.89% |
| 2 | Nanobiotix | 1,925.70 Bn | 1,925.64 Bn | - | - |
| 3 | Akari Therapeutics | 1,062.88 Bn | 1,062.88 Bn | - | - |
| 4 | BeOne Medicines | 469.09 Bn | 464.29 Bn | 1.35 Bn | 2,150.96% |
| 5 | Vertex Pharmaceuticals | 123.09 Bn | 115.84 Bn | 2.59 Bn | 80.62% |
| 6 | Regeneron Pharmaceuticals | 70.32 Bn | 61.57 Bn | 3.31 Bn | 8.65% |
| 7 | Belite Bio | 63.36 Bn | 63.36 Bn | - | - |
| 8 | Argenx Se | 55.90 Bn | 50.71 Bn | 1.41 Bn | 145.20% |
| 9 | Alnylam Pharmaceuticals | 37.69 Bn | 34.68 Bn | 959.66 Mn | 1,386.07% |
| 10 | Mirum Pharmaceuticals | 6.73 Bn | 6.34 Bn | 131.08 Mn | -5,099.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,099.66% |
| Dec 31, 2025 | 81.15% |
| Sep 30, 2025 | 120.52% |
| Jun 30, 2025 | 79.41% |
| Mar 31, 2025 | 42.64% |
| Dec 31, 2024 | 25.67% |
| Sep 30, 2024 | 49.56% |
| Jun 30, 2024 | 0.17% |
| Mar 31, 2024 | 2.50% |
| Dec 31, 2023 | 4.61% |
| Sep 30, 2023 | 23.52% |
| Jun 30, 2023 | 22.80% |
| Mar 31, 2023 | 17.07% |
| Dec 31, 2022 | 25.04% |
| Sep 30, 2022 | 23.22% |
| Jun 30, 2022 | 15.94% |
| Mar 31, 2022 | 31.25% |
| Dec 31, 2021 | -23.34% |
| Sep 30, 2021 | -97.20% |
| Jun 30, 2021 | -58.50% |